Continuum Advisory’s AstraZeneca AZN Stock Holding History

Continuum Advisory's AZN Position: Q2 2026 in Review

Continuum Advisory opened a new position in AstraZeneca (AZN) in Q2 2026: 875 shares worth $166K. The stake represents 0.01% of the portfolio and ranks #506 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in AZN as recently as Q1 2025.

Continuum Advisory first reported a position in AZN in Q1 2024 and has held it in 6 quarters since. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

• Continuum Advisory held 875 shares of AstraZeneca worth $166K as of Q2 2026.
• AstraZeneca was a new Continuum Advisory position in Q2 2026.
• AstraZeneca made up 0.01% of Continuum Advisory's portfolio in Q2 2026, its #506 holding.
• Continuum Advisory first reported a position in AstraZeneca in Q1 2024 and has held it in 6 quarters since.
• 1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.